Current Problems in Cancer: Case Reports · Published 2026-07-13 · DOI 10.1016/j.cpccr.2026.100431
Pranav Ravipati, Rizvan Azimzade, Missak Haigentz
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Ravipati, P., Azimzade, R., Haigentz, M. (2026). Strong response to first-line osimertinib and chemotherapy in EGFR L861Q-mutant NSCLC: a case report. Current Problems in Cancer: Case Reports. https://doi.org/10.1016/j.cpccr.2026.100431